Loading…

Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma

Summary Imbalances in the composition of BCL2 family proteins contribute to tumourigenesis and therapy resistance of mantle cell lymphoma (MCL), making these proteins attractive therapy targets. We studied the efficiency of dual targeting the NOXA/MCL1 axis by combining fatty acid synthase inhibitor...

Full description

Saved in:
Bibliographic Details
Published in:British journal of haematology 2017-05, Vol.177 (4), p.557-561
Main Authors: Höring, Elisabeth, Montraveta, Arnau, Heine, Simon, Kleih, Markus, Schaaf, Lea, Vöhringer, Matthias C., Esteve‐Arenys, Anna, Roué, Gael, Colomer, Dolors, Campo, Elias, Ott, German, Aulitzky, Walter E., Kuip, Heiko
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Imbalances in the composition of BCL2 family proteins contribute to tumourigenesis and therapy resistance of mantle cell lymphoma (MCL), making these proteins attractive therapy targets. We studied the efficiency of dual targeting the NOXA/MCL1 axis by combining fatty acid synthase inhibitors (NOXA stabilization) with the CDK inhibitor Dinaciclib (MCL1 reduction). This combination synergistically induced apoptosis in cell lines and primary MCL cells and led to almost complete inhibition of tumour progression in a mouse model. Apoptosis was NOXA‐dependent and correlated with the NOXA/MCL1 ratio, highlighting the importance of the NOXA/MCL1 balance for effective cell death induction in MCL.
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.14571